Search Within

Madhav Dhodapkar

Formats
  1. Journal Article (29)
  2. Meeting Abstract (12)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (15)
  2. Hematologic Malignancies, Division of (15)
  3. Center for Hematologic Malignancies (13)
  4. Adult Leukemia (12)
  5. Myeloma (10)
  6. Nursing (4)

More Groups

People
  1. Raymond Comenzo (13)
  2. Virginia Klimek (12)
  3. Julie Feldstein (11)
  4. Martin Fleisher (11)
  5. Stephen Nimer (11)
  6. Tarun Kewalramani (11)

More People

Years
  1. 2007 (1)
  2. 2006 (6)
  3. 2005 (12)
  4. 2004 (3)
  5. 2003 (12)
  6. 2002 (6)

More Years

Publications
  1. Blood (16)
  2. Journal of Experimental Medicine (4)
  3. British Journal of Haematology (3)
  4. Journal of Immunotherapy (3)
  5. Proceedings of the National Academy of Sciences of the United States of America (3)
  6. Cancer Immunology, Immunotherapy (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. John Wiley & Sons (5)
  3. Rockefeller University Press (4)
  4. Elsevier Inc. (3)
  5. Lippincott Williams & Wilkins (3)
  6. National Academy of Sciences (3)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
    Journal Article

    Dhodapkar, M. V.; Osman, K.; Teruya-Feldstein, J.; Filippa, D.; Hedvat, C. V.; Iversen, K.; Kolb, D.; Geller, M. D.; Hassoun, H.; Kewalramani, T.; more...
    Cancer Immunity (2003)

    Fulltext@MSK | Save
  • Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy
    Journal Article

    Dhodapkar, M. V.; Krasovsky, J.; Osman, K.; Geller, M. D.
    Journal of Experimental Medicine (2003)

    Fulltext@MSK | Save
  • Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003)
    Journal Article

    Dhodapkar, M. V.; Jacobson, J. L.; Gertz, M. A.; Crowley, J. J.; Barlogie, B.
    Seminars in Oncology (2003)

    Fulltext@MSK | Save
  • A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
    Journal Article

    Dhodapkar, M. V.; Geller, M. D.; Chang, D. H.; Shimizu, K.; Fujii, S. I.; Dhodapkar, K. M.; Krasovsky, J.
    Journal of Experimental Medicine (2003)

    Fulltext@MSK | Save
  • Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients
    Meeting Abstract

    Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • T cells from the tumor microenvironment of patients with progressive myeloma can generate strong tumor specific cytolytic responses to autologous tumor-loaded dendritic cells
    Meeting Abstract

    Dhodapkar, M. V.; Krasovsky, J.; Olson, K.
    Blood (2002)

    Fulltext@MSK | Save
  • The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells
    Journal Article

    Berger, C. L.; Hanlon, D.; Kanada, D.; Dhodapkar, M.; Lombillo, V.; Wang, N.; Christensen, I.; Howe, G.; Crouch, J.; El-Fishawy, P.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
    Journal Article

    Dhodapkar, M. V.; Steinman, R. M.
    Blood (2002)

    Fulltext@MSK | Save
  • T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells
    Journal Article

    Dhodapkar, M. V.; Krasovsky, J.; Olson, K.
    Proceedings of the National Academy of Sciences of the United States of America (2002)

    Fulltext@MSK | Save
  • Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells
    Journal Article

    Dhodapkar, K. M.; Krasovsky, J.; Williamson, B.; Dhodapkar, M. V.
    Journal of Experimental Medicine (2002)

    Fulltext@MSK | Save